METHODS FOR REDUCING THE RISK OF DEATH DUE TO CARDIOVASCULAR MORTALITY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS BY USING EMPAGLIFLOZIN

摘要

The present invention relates to a method for reducing the risk of death due to cardiovascular pathology or heart failure requiring hospitalization in a patient with type 2 diabetes mellitus and wherein said patient has a cardiovascular disease or at risk of a cardiovascular disease, characterized in that empagliflozin is administered to the patient orally in a total daily amount of 10 or 25 mg. The present invention further relates to a method for reducing the risk of death in all lethal cases by reducing the risk of death due to cardiovascular mortality in a patient with type 2 diabetes mellitus and wherein the patient has a cardiovascular disease or at risk of a cardiovascular disease, characterized in that empagliflozin is administered orally in a total daily amount of 10 or 25 mg.